Investor Views: "I’m Sticking with Biotech Stocks – Despite 50% Falls"

Private investor Chris Morris has invested in a range of high risk sectors, but says he’s yet to see positive returns

Emma Simon 21 June, 2017 | 3:53PM
Facebook Twitter LinkedIn

Chris Morris says his parents encouraged him to invest. “They opened an ISA for me when I was 18. But, quite sensibly, they didn’t tell me about it at the time.” Over the next few years they continued to contribute to a range of funds, that performed well, giving Morris a small nest egg by the time he reached his mid-20s.

He started investing himself into the ISA at the age of 25. He says: “I invest on a regular basis, putting aside a little each month. I’ve tried to expand the number of funds I invest in, though looking at the performance over the past three years, the fund picked by my parents have performed a bit better.”

As these are long-term investments Morris – and his parents – have invested in higher risk sectors. Morris says he has tried to be a bit more adventurous than his parents, but this gamble has not always paid off.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AXA Framlington Biotech R Acc248.80 GBP-0.20Rating
BlackRock Gold and General D Inc1,223.08 GBP-0.80Rating
FSSA Greater China Growth I USD Acc151.62 USD-0.47Rating
FSSA Indian Subcontinent I USD Acc141.39 USD0.19Rating
Liontrust Russia A Acc GBP6.23 GBP1.04Rating
Marlborough Special Situations A Acc2,472.58 GBP0.30Rating

About Author

Emma Simon

Emma Simon  is a financial journalist, specialising in investment and consumer issues, writing for